![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Pisu M. Meltzer M.I. Lyerla R.
Publisher: Elsevier
ISSN: 0264-410X
Source: Vaccine, Vol.21, Iss.3, 2002-12, pp. : 312-321
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness
Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The cost-effectiveness of varicella vaccination in Canada
Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The cost of hepatitis C and the cost-effectiveness of its prevention
Health Policy, Vol. 58, Iss. 2, 2001-11 ,pp. :